Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of SK-1405 in subjects with or without hepatic impairment
jRCT2080223781Phase 1Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of SK-1405 in hepatic impairment and Cirrhosis (2 arms), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoint: Pharmacokinetics of SK-1405. Started Jan 2018; status: completed.
02
Drugs
SK-1405
03
Conditions
hepatic impairmentCirrhosis
Beyond the preview
Go deeper on jRCT2080223781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223781.